ADLM 2024 (American Diagnostics and Laboratory Medicine)

28 Jul-1 Aug 2024 | Sun, 07/28/2024 - 00:00 Thu, 08/01/2024 - 00:00

Connect with Labcorp at ADLM 2024

July 28 - August 1, 2024 | Chicago, IL

Scientific Session	Session Time	Speakers
[33225] Care Continuum: How Hematologists, Laboratorians, and Transfusion Medicine Physicians Partner to Diagnose, Manage, and Support Patients with Sickle Cell Disease	Tuesday, July 30, 2:30PM - 4:00PM	Moderator: Labcorp’s Zahra Shajani-Yi, PhD, DABCC, NRCC, FADLM Speakers: Susanna Curtis, MD, PhD, Icahn School of Medicine at Mt. Sinai Sean Campbell, PhD, DABCC, FADLM, Montefiore Medical Center Caroline Alquist, MD, PhD, F(ACHI), FCAP, University of Cincinnati
[33227] Metabolic Emergencies in the Pediatric Patient: Laboratory Differentiation of Inborn Errors of Metabolism and Acute Drug Exposure	Tuesday, July 30, 2:30PM - 4:00PM	Moderator: Kara Lynch, PhD, DABCC, FADLM, University of California, San Francisco Speakers: Labcorp’s Sydney Strickland, PhD, DABCC Kara Lynch, PhD, DABCC, FADLM, University of California, San Francisco
[34222] Best Practices and Innovations in Clinical and Technical Consultation by Medical Laboratory Professionals	Wednesday, July 31, 2:30PM - 4:00PM	Moderator/Speaker: Labcorp’s Nadia Ayala-Lopez, PhD, MLS (ASCP), DABCC, NRCC Speakers: Alejandro Molinelli, PhD, NRCC, St. Jude Children's Research Hospital Medical Laboratory Consultations Nadia Ayala-Lopez, PhD, MLS (ASCP), DABCC, NRCC, Labcorp
[35102] Preeclampsia in the United States: Clinical Details, Best Practices in Laboratory Medicine, and Impact of Foundational Support	Thursday, August 1, 10:30AM - 12:00PM	Moderator/Speaker: Labcorp’s Sydney Strickland, PhD, DABCC Speakers: Emily Rosenfeld, DO, Rutgers Robert Wood Johnson Medical School Laney Poye, MIA, Preeclampsia Foundation

Tuesday, July 30 – Poster Session 1: 9:30AM – 5:00PM
Poster #	Poster Title	Presentation Time	Presenter & Authors
A-074	A Laboratory Developed Serum Anti-Mullerian Hormone Electrochemiluminescent Immunoassay: Performance and Retrospective Analysis of Over 2.2 Million Tests in Females and Males Across Lifespan	Tuesday, 7/30 1:30PM – 2:30PM	Presenter: David Alfego Authors: D. Alfego, C. Cheng, M. Bastidas, B. Bauer, K. Chun
A-086*	Clinical Performance of a Plasma ATN Panel for Assessment of Alzheimer’s Disease	Tuesday, 7/30 1:30PM – 2:30PM	Presenter: Brad Collier Authors: B. B. Collier, W. C. Brandon, M. R. Chappell, A. B. Harris, T. Le, R. L. Martone, J. M. Volpe, D. Boles, A. Valcour, R. P. Grant
A-264	Valildation of a Novel Real-Time PCR Assay for Identification of Mycobacterium species Isolates Recovered from Clinical Culture	Tuesday, 7/30 1:30PM – 2:30PM	Presenter: Ayla Burns Authors: A. B. Harris, R. Jadi, T. J. Urban, T. Le, K. Song, H. N. Brochu, L. K. Iyer, S. E. Dale, G. A. Capraro, D. J. Boles
A-318	Validation of umbilical cord blood as an alternate sample type for quantitative in vitro detection of glucose-6-phosphate dehydrogenase in neonates	Tuesday, 7/30 1:30PM – 2:30PM	Presenter: Authors: E. Donovan, A. Katayev, R. Young, L. Jodry, S. Patel1, E. Halabi, J. Turpie, R. Patel, R. Patel, C. Patel, D. Patel, A. Hawley
A-319	Capillary Blood Collection for Egg-cellent Reproductive Insights	Tuesday, 7/30 1:30PM – 2:30PM	Presenter: Whitney Brandon Authors: W. C. Brandon, B. B. Collier, M. R. Chappell, G. Iacovetti, M. Peevler, U. Y. Schaff, G. J. Sommer, R. P. Grant
A-357	Evaluation of a home kit for lay user collection, centrifugation, and refrigeration of capillary blood specimens	Tuesday, 7/30 1:30PM – 2:30PM	Presenter: Gabriella Iacovetti Authors: G. Iacovetti, N. Tokunaga, M. Peevler, J. Ragar, G. J. Sommer, U. Y. Schaff
Wednesday July 31 – Poster Session 2: 9:30AM – 5:00PM
B-051	Clinical Validation of Vectra® DA: A Multi-Biomarker Based Test for the Objective Measurement of Disease Activity in Patients with Rheumatoid Arthritis.	Wednesday, 7/31 1:30PM – 2:30PM	Presenter: Kelly Chun Authors: K. Chun, F. Bytyqi, B. Holmquist, J. Lopez, M. Zikry, L. Leal, M. Nappi, D. Boles, S. Parker, B. Bauer, M. Bastidas
B-266	Therapeutic Drug Monitoring of Natalizumab and Anti-Natalizumab Antibodies	Wednesday, 7/31 1:30PM – 2:30PM	Presenter: Kelly Chun Authors: K. Chun, B. Bauer, M. Bastidas, M. Zikry, J. Yang
B-103	Correlation of Novel Markers, Anti-Sa (Citrullinated Vimentin) and Anti-CarP (Carbamylated Protein), with High Vectra® DA Disease Activity Scores in Rheumatoid Arthritis (RA)	Wednesday, 7/31 1:30PM – 2:30PM	Presenter: Jane Yang, MD Authors: J. M. Yang, R. Punzalan, M. Nappi, K. Y. Chu
B-105	Farr Radioimmunoprecipitation Method Enhances Serial Monitoring of Quantitative Anti-dsDNA (double-stranded) Antibody Measurements in Lupus	Wednesday, 7/31 1:30PM – 2:30PM	Presenter: Jane Yang, MD Authors: J. M. Yang, L. Yeo, W. Galdamezmelgar, M. Bastidas, K. Y. Chun
B-302	Therapeutic Drug Monitoring (TDM) of Hydroxychloroquine in Whole Blood: Analysis of Over 10,000 Patient Results	Wednesday, 7/31 1:30PM – 2:30PM	Presenter: Jane Yang, MD Authors: J. M. Yang, B. Holmquist, K. Y. Chun
B-104	Correlation of Anti-Centromere Antibodies (ACA) Detection by Indirect Immunofluorescence (IFA) on HEp-2 Cells and by ELISA Demonstrates High Concordance but Highlights Advantage of IFA	Wednesday, 7/31 1:30PM – 2:30PM	Presenter: Jane Yang, MD Authors: J. M. Yang, R. Punzalan, M. Nappi, S. Purohit, K. Y. Chun
B-098	Clinical comparison of five assays for the detection of anti-dsDNA antibodies and their correlation with complement consumption	Wednesday, 7/31 1:30PM – 2:30PM	Presenter: Vincent Ricchiuti, PhD Authors: Vincent Ricchiuti, Brooke Holloway2, Mary-Ann Aure, Chelsea Bentow, Michael Mahler

*Distinguished abstract recognition